May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study describes a novel cancer therapy, ONCO-NK-TRANSITION-GM1, that offers a 60-80% cure rate across multiple cancer types using existing pharmaceutical manufacturing technologies, and costs $50 per dose, presenting a more accessible alternative to current therapies.
September 2023 in “SKIN The Journal of Cutaneous Medicine” This case report documented a 74-year-old female with alopecic patches and other skin issues during talquetamab therapy for multiple myeloma, suggesting that the drug may cause skin-related adverse effects due to reactivity to GPRC5D-expressing structures.
January 2020 in “International Journal of PharmTech Research” This case report describes a patient with untreated lepromatous leprosy developing Lucio's phenomenon, highlighting difficulties in distinguishing it from erythema nodosum leprosum with vasculonecrotic lesions.
October 2025 in “Pharmaceutics” This study highlights the clinical potential of microneedles as an innovative transdermal drug delivery system for treating various skin diseases with minimal pain and high patient compliance.
12 citations
,
July 2025 in “Journal of Clinical and Translational Hepatology” This review discusses how targeting TGF-β with specific inhibitors, including components from Traditional Chinese Medicine, may help reduce liver fibrosis by acting through various signaling pathways.
